*Correspondence: Marco Centanni, [email protected] This article was submitted to Thyroid Endocrinology, a section of the journal Frontiers in Endocrinology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
[DOI] [PMC free article] [PubMed] [Google Scholar] [94].Yamazaki Y, Harada S, Wada T, Hagiwara T, Yoshida S, Tokuyama S, European Journal of Pharmacology 2017, 799, 103
Whether that tool is appropriate for your specific situation is a medical determination - one only a licensed clinician can make
Zepbound is FDA-approved along with lifestyle changes for: Weight loss in adults with obesity or with overweight and a weight-related health condition, such as high blood pressure or type 2 diabetes Obstructive sleep apnea (OSA) in adults with obesity Saxenda (liraglutide) Like Wegovy and Zepbound, Saxenda is another GLP-1 agonist approved for weight management alongside diet and exercise
The expectation gap is massive